A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
PHASE4CompletedINTERVENTIONAL
Enrollment
42
Participants
Timeline
Start Date
May 31, 2014
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG
Retaine™
Trial Locations (1)
01810
Andover
All Listed Sponsors
collaborator
ORA, Inc.
INDUSTRY
lead
Ocusoft, Inc.
INDUSTRY
NCT02139033 - A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome | Biotech Hunter | Biotech Hunter